[ad_1] FORT WORTH, Texas, Dec. 17, 2025 /PRNewswire/ — NanOlogy, LLC, a clinical-stage oncology company, today announced the appointment of David Arthur as Chief Executive Officer. This appointment reflects a pivotal step in NanOlogy’s commitment […]
